5 Massachusetts Biotechs That Tanked More Than 60% in 2017 Post author:Sam Post published:January 1, 2018 Post category:BioPharma This is definitely a list few, if any, companies want to be on. Source: BioSpace You Might Also Like FDA Lashes Out at Jazz Pharma CMO for Continued Regulatory Violations January 26, 2017 Eli Lilly’s Verzenio Picks Up Third Approved Indication February 26, 2018 Ex-Genentech Employees' Denali Breaks 2017 IPO Records, Raises $250M December 7, 2017
